Pierre Fabre SA
Pierre Fabre SA
🇫🇷 France, Occitanie
1951More than 10000 peopleManufacturer/Service CompanyPierre Fabre SA is a leading French pharmaceutical and dermo-cosmetic group headquartered in Castres, France. Established in 1962, the company has grown into a global healthcare leader, ranking as the world's second-largest dermo-cosmetics manufacturer and the second-largest private pharmaceutical group in France. With a workforce of over 10,000 employees across 43 global locations, the company reported revenues of 3.1 billion euros in 2024. Pierre Fabre operates with a unique ownership structure, being 86% owned by the Pierre Fabre Foundation, a government-recognized public-interest foundation.
The company specializes in a dual-expertise model, integrating medical innovation with botanical expertise. Its extensive product portfolio includes prescription drugs, oncology therapies, and dermo-cosmetic solutions for skin, hair, and oral health. Key brands include Eau Thermale Avène, Klorane, Ducray, René Furterer, A-Derma, and Pierre Fabre Oral Care. Their therapeutic focus spans oncology, dermatology, pediatrics, and venous disorders, while their dermo-cosmetic lines address conditions such as acne, eczema, and skin aging.
As a vertically integrated manufacturer, Pierre Fabre produces over 95% of its products in France and offers contract development and manufacturing (CDMO) services. The group is heavily invested in research and development, with dedicated innovation centers in Toulouse, Shanghai, and Rio de Janeiro focusing on oncology and medical care. The company is recognized for its commitment to Corporate Social Responsibility (CSR), holding the "Exemplary" level certification from AFNOR.
OEM manufacturerOffers OEM services for customized brand manufacturing.
Own brandOwns and operates its own brands and manufacturing facilities.
High capacity factoryCan handle large-scale or bulk production orders.
Established brandFounded in 1951, with over 20 years of industry experience.
Contact
**********************
1
*************
1
Products
Nerlynx
MEKTOVI
Eau Thermale Avène
Dermo-cosmetics development charter
BRAFTOVI
Customers
ASTOR
************
************
*************************
***************
Unlock all 6 customers
Ask AI about this supplier
Key export market
Shipments
Shipments count
0
Export volume
0 kg
Export countries
0
Customers
0
Insights
Top 5 customers
Reflecting the depth of cooperation between supplier and customersTop 5 customers
This insight is only available in the Pro planTop 5 export countries
Reflecting the supplier's export experience in target countriesTop 5 export countries
This insight is only available in the Pro planShipment count distribution
Reflecting the supplier's market business activityAll categories
Shipment count distribution
This insight is only available in the Pro planExport weight distribution (kg)
Reflecting the supplier's export scaleAll categories
Export weight distribution (kg)
This insight is only available in the Pro planExport weight trend (kg)
Reflecting the growth rate of the supplier's phased total supply volume and the fluctuation of supply volume, identifying supply peaks and troughsAll categories
Export weight trend (kg)
This insight is only available in the Pro planCIF trend (USD)
For identifying high-value cooperation periods and single order value changesAll categories
CIF trend (USD)
This insight is only available in the Pro planSimilar suppliers you may like
Pymepharco Joint Stock Company
🇻🇳 Vietnam
19891001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
604
Key customer
MERIEUX NUTRISCIENCES
Key market
🇻🇳 Vietnam
Description
Pymepharco Joint Stock Company is a leading pharmaceutical manufacturer and distributor based in Tuy Hoa, Vietnam. Established as a subsidiary of the global STADA Group, the company has evolved from a local medical supplier into a major regional player with a workforce of over 1,000 employees. Pymepharco specializes in the production of high-quality generic pharmaceuticals, prescription drugs, and OTC medicines, with a particular focus on antibiotics such as Cephalosporin. Their extensive product portfolio includes analgesics, antipyretics, anti-inflammatory drugs, vitamins, minerals, and dietary supplements, as well as medical equipment and medicinal chemicals.
The company operates advanced manufacturing facilities, including the modern PME II factory, which features a production capacity of 1.2 billion tablets per shift annually. Pymepharco is distinguished as a pioneer in Vietnam for achieving EU-GMP standards, ensuring their injectable powders, tablets, soft and hard capsules, and granules meet international quality benchmarks. In addition to its own branded products, the company provides OEM services and maintains strategic partnerships with international firms like Enzymatica. As a key contributor to the Southeast Asian pharmaceutical supply chain, Pymepharco focuses on delivering affordable, high-quality healthcare solutions through sustainable development and advanced scientific applications.
Pymepharco Building
Sanofi Vietnam Shareholding Company
🇻🇳 Vietnam
501-1000 peopleManufacturer/Trading CompanyHigh capacity factory
Own brand
Patented technology
Industry association member
Shipments
4080
Key customer
OPELLA
Key market
🇻🇳 Vietnam
Description
Sanofi Vietnam Shareholding Company is a leading pharmaceutical manufacturer and trading entity based in Ho Chi Minh City, operating as a subsidiary of the French global healthcare group Sanofi. With over 70 years of presence in Vietnam, the company employs between 500 and 1,000 professionals and operates a state-of-the-art factory in the Saigon Hi-Tech Park. The facility is highly certified, holding TGA-GMP, WHO-GMP, and EU-GMP standards, and the company is recognized as a B Corp certified organization. Sanofi Vietnam specializes in a diverse healthcare portfolio including vaccines, general medicines, and consumer healthcare products such as vitamins, minerals, and supplements (VMS). Their extensive product range covers therapeutic areas such as cardiology, oncology, digestive health, and infectious diseases, featuring well-known brands like Calcium Corbiere, Enterogermina, and Lactacyd. As a key player in the regional market, the company provides contract manufacturing and OEM services, leveraging its Research and Development Centre to drive innovation. Sanofi Vietnam is also a significant international trader, managing a high volume of import and export shipments of pharmaceutical ingredients, biologicals, and specialized medical equipment like HPLC columns. Recent strategic partnerships have further expanded their capabilities into the local production of essential vaccines and biologicals, reinforcing their commitment to national health security and the broader Southeast Asian market.
Enoxaparin sodium Impact
Dulcoflex® 5mg Tablets
vaccine
Pharmaceutical Products
vaccines
From Molecule to Medicine: Journey Through CMC Development l Sanofi
Plavix
